Vignette Bio Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $370M

Vignette Bio General Information

Description

Developer of novel therapies designed to address immunology and inflammation-associated diseases. The company is currently operating in stealth mode.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 11622 El Camino Real
  • Suite 150
  • San Diego, CA 92130
  • United States
+1 (858)
Primary Industry
Drug Discovery
Parent Company
Vertical(s)
Corporate Office
  • 11622 El Camino Real
  • Suite 150
  • San Diego, CA 92130
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vignette Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 19-Aug-2024 $370M Completed Stealth
1. Early Stage VC (Series A) 07-Aug-2024 Completed Stealth
To view Vignette Bio’s complete valuation and funding history, request access »

Vignette Bio Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Foresite Capital Growth/Expansion Minority
Mirae Asset Capital Life Science Venture Capital Minority
Qiming Venture Partners Venture Capital Minority
Samsara BioCapital Venture Capital Minority
To view Vignette Bio’s complete investors history, request access »

Vignette Bio FAQs

  • When was Vignette Bio founded?

    Vignette Bio was founded in 2023.

  • Where is Vignette Bio headquartered?

    Vignette Bio is headquartered in San Diego, CA.

  • What industry is Vignette Bio in?

    Vignette Bio’s primary industry is Drug Discovery.

  • Is Vignette Bio a private or public company?

    Vignette Bio is a Private company.

  • What is the current valuation of Vignette Bio?

    The current valuation of Vignette Bio is .

  • What is Vignette Bio’s current revenue?

    The current revenue for Vignette Bio is .

  • How much funding has Vignette Bio raised over time?

    Vignette Bio has raised $105M.

  • Who are Vignette Bio’s investors?

    Foresite Capital, Mirae Asset Capital Life Science, Qiming Venture Partners, and Samsara BioCapital have invested in Vignette Bio.

  • When was Vignette Bio acquired?

    Vignette Bio was acquired on 19-Aug-2024.

  • Who acquired Vignette Bio?

    Vignette Bio was acquired by Candid Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process